Latest

Registers› Irish medicines

Medicines register · Ireland

Every medicine authorised for the Irish market

The Health Products Regulatory Authority's full list of authorised products — brand, active substance, licence holder, licence number and market status. Filter it, cite it, and take it away as a file.

Source: HPRA open dataset ("Authorised or Transfer Pending Products"), CC BY 4.0. Complete coverage — all 10,336 authorised products are in this register. Synced 20 Sep 2026, 17:51 UTC

Narrow the register Reset

Search within results

Matches brand name, active substance, licence holder and licence number.

Browse by first letter

A B C D E F G H I J K L M N O P Q R S T U V W X Y Z 0–9

Medicine

Active substance

Licence holder

Status

Acular 0.5% w/v Eye Drops, solution PA1824/015/001

Ketorolac trometamol

Marketed

Alphagan 0.2% w/v (2 mg/ml) eye drops, solution PA1824/007/001

Brimonidine tartrate

Marketed

AQUIPTA 10 mg tablets EU/1/23/1750/001-002

Atogepant monohydrate

AbbVie Deutschland GmbH & Co. KG

—

AQUIPTA 60 mg tablets EU/1/23/1750/003-004

Atogepant monohydrate

AbbVie Deutschland GmbH & Co. KG

—

Betagan 0.5% w/v Unit Dose Eye Drops, Solution PA1824/012/001

Levobunolol hydrochloride

Not marketed

BOTOX 100 Allergan Units powder for solution for injection PA1824/017/001

Botulinum Toxin Type A

Marketed

BOTOX 200 Allergan Units powder for solution for injection PA1824/017/003

Botulinum Toxin Type A

Marketed

BOTOX 50 Allergan Units powder for solution for injection PA1824/017/002

Botulinum Toxin Type A

Marketed

Celluvisc 0.5 % w/v eye drops solution, unit dose PA1824/016/002

Carmellose sodium

Marketed

Celluvisc 1% w/v Eye drops, solution, unit dose PA1824/016/001

Carmellose sodium

Marketed

Combigan 2 mg/ml + 5 mg/ml eye drops, solution PA1824/019/001

Brimonidine tartrate, Timolol Maleate

Not marketed

Constella 290 micrograms hard capsules EU/1/12/801/001-004

Linaclotide

AbbVie Deutschland GmbH & Co. KG

—

Duodopa 20 mg/ml + 5 mg/ml intestinal gel PA1824/002/001

Levodopa, Carbidopa

Marketed

EXOCIN (Ofloxacin) 0.3% w/v Eye Drops Solution PA1824/014/001

Ofloxacin

Marketed

FML 0.1% w/v Eye Drops Suspension PA1824/008/001

Fluorometholone

Not marketed

Ganfort 0.3 mg/ml + 5 mg/ml eye drops, solution EU/1/06/340/001-002

Bimatoprost, Timolol

AbbVie Deutschland GmbH & Co. KG

—

Humira 20 mg solution for injection in pre-filled syringe EU/1/03/256/022

Adalimumab

AbbVie Deutschland GmbH & Co. KG

—

Humira 40 mg/0.8 ml solution for injection EU/1/03/256/1-10

Adalimumab

AbbVie Deutschland GmbH & Co. KG

—

Humira 80 mg solution for injection in pre-filled syringe EU/1/03/256/020

Adalimumab

AbbVie Deutschland GmbH & Co. KG

—

Kaletra EU/1/01/172/4-5,7-8

Lopinavir, Ritonavir

AbbVie Deutschland GmbH & Co. KG

—

Kaletra (80 mg + 20 mg)/ml oral solution EU/1/01/172/003

Ritonavir, Lopinavir

AbbVie Deutschland GmbH & Co. KG

—

Kaletra 100 mg/25 mg film-coated tablets EU/1/01/172/006

Ritonavir, Lopinavir

AbbVie Deutschland GmbH & Co. KG

—

Lumigan 0.1 mg/ml eye drops, solution EU/1/02/205/3-4

Bimatoprost

AbbVie Deutschland GmbH & Co. KG

—

Lumigan 0.3 mg/ml eye drops, solution EU/1/02/205/001-2

Bimatoprost

AbbVie Deutschland GmbH & Co. KG

—

Maviret 100 mg/40 mg film-coated tablets EU/1/17/1213/001

Pibrentasvir, Glecaprevir

AbbVie Deutschland GmbH & Co. KG

—

Maviret 50 mg/20 mg coated granules in sachet EU/1/17/1213/003

Glecaprevir, Pibrentasvir

AbbVie Deutschland GmbH & Co. KG

—

Norvir 100 mg film-coated tablets EU/1/96/016/005-006

Ritonavir

AbbVie Deutschland GmbH & Co. KG

—

Norvir 100 mg powder for oral suspension EU/1/96/016/009

Ritonavir

AbbVie Deutschland GmbH & Co. KG

—

OZURDEX 700 micrograms intravitreal implant in applicator EU/1/10/638/001

Dexamethasone

AbbVie Deutschland GmbH & Co. KG

—

Pred Forte 1% w/v, Eye Drops Suspension PA1824/010/001

Prednisolone acetate

Marketed

Pred Mild Sterile Ophthalmic Suspension, 0.12% w/v, Eye Drops, Suspension PA1824/009/001

Prednisolone acetate

Not marketed

Produodopa 240 mg/ml + 12 mg/ml solution for infusion PA1824/002/003

Foslevodopa, Foscarbidopa

Marketed

Relestat, 0.5 mg/ml, eye drops, solution PA1824/018/001

Epinastine hydrochloride

Not marketed

RINVOQ 15 mg prolonged-release tablets EU/1/19/1404/001-005

UPADACITINIB, Upadacitinib Hemihydrate

AbbVie Deutschland GmbH & Co. KG

—

RINVOQ 30 mg prolonged-release tablets EU/1/19/1404/006-009

Upadacitinib Hemihydrate

AbbVie Deutschland GmbH & Co. KG

—

RINVOQ 45 mg prolonged-release tablets EU/1/19/1404/010-011

Upadacitinib Hemihydrate

AbbVie Deutschland GmbH & Co. KG

—

Sevorane 100% v/v Inhalation Gas PA1824/004/001

Sevoflurane

Marketed

Skyrizi 150 mg Solution for injection EU/1/19/1361/003

RISANKIZUMAB

AbbVie Deutschland GmbH & Co. KG

—

Skyrizi 150 mg Solution for injection EU/1/19/1361/002

RISANKIZUMAB

AbbVie Deutschland GmbH & Co. KG

—

Skyrizi 180 mg Solution for injection EU/1/19/1361/007

RISANKIZUMAB

AbbVie Deutschland GmbH & Co. KG

—

Skyrizi 180 mg solution for injection in pre-filled syringe EU/1/19/1361/008-009

RISANKIZUMAB

AbbVie Deutschland GmbH & Co. KG

—

Skyrizi 360 mg Solution for injection EU/1/19/1361/005

RISANKIZUMAB

AbbVie Deutschland GmbH & Co. KG

—

Skyrizi 55 mg solution for injection in pre-filled syringe EU/1/19/1361/010

RISANKIZUMAB

AbbVie Deutschland GmbH & Co. KG

—

Skyrizi 600 mg Concentrate for solution for injection EU/1/19/1361/004

RISANKIZUMAB

AbbVie Deutschland GmbH & Co. KG

—

Skyrizi 75 mg Solution for injection EU/1/19/1361/001

RISANKIZUMAB

AbbVie Deutschland GmbH & Co. KG

—

Skyrizi 90 mg Solution for injection EU/1/19/1361/006

RISANKIZUMAB

AbbVie Deutschland GmbH & Co. KG

—

Tepkinly 4 mg/0.8 ml solution for injection EU/1/23/1759/001

Epcoritamab

AbbVie Deutschland GmbH & Co. KG

—

Tepkinly 48 mg solution for injection EU/1/23/1759/002

Epcoritamab

AbbVie Deutschland GmbH & Co. KG

—

Venclyxto 10 mg film-coated tablets EU/1/16/1138/001-002

Venetoclax

AbbVie Deutschland GmbH & Co. KG

—

Venclyxto 100 mg film-coated tablets EU/1/16/1138/005-007

Venetoclax

AbbVie Deutschland GmbH & Co. KG

—

Cite this view

Priya Life Science (2026). Irish Medicines Register, filtered. Derived from the HPRA open dataset. Retrieved 28 September 2026. https://priyalifescience.com/medicines

Download this register

GET /api/export.php?register=medicines-ie&format=csv Try the JSON export →

Regulatory information only — not medical advice. For the authoritative record see the HPRA register directly.